Neuroimaging pharmacopoeia / / editors, Daniel Thomas Ginat, Juan E. Small, Pamela W. Schaefer

• Pubblicazione: Cham, Switzerland : , : Springer, , 2022
• Edizione: Second edition.
• Descrizione fisica: 1 online resource (413 pages)
• Disciplina: 616.804754
• Soggetto topico: Brain - Imaging; Drug interactions
• Persona (resp. second.): GinatDaniel Thomas; SmallJuan E.; SchaeferPamela W.
• Nota di contenuto: Intro -- Contents -- Part I: Drugs and Alcohol -- 1: Tobacco -- 1.1 Uses -- 1.2 Mechanism -- 1.3 Imaging Findings -- 1.3.1 Stroke -- 1.3.2 Cerebral Aneurysm -- 1.3.3 Cerebral Venous Thrombosis -- 1.3.4 Head and Neck Cancer, Squamous Cell Carcinoma -- 1.3.5 Brain Metastases -- 1.3.6 Warthin Tumor -- 1.3.7 Smoking-Induced Nasopharyngeal Lymphoid Hyperplasia -- Suggested Reading -- 2: Alcohol -- 2.1 Uses -- 2.2 Mechanism -- 2.3 Imaging Findings -- Suggested Reading -- 3: Methanol -- 3.1 Uses -- 3.2 Mechanism -- 3.3 Imaging Findings -- 3.4 Differential Diagnosis -- Suggested Reading -- 4: Cannabis (Marijuana) -- 4.1 Uses -- 4.2 Mechanism -- 4.3 Imaging Findings -- 4.4 Differential Diagnosis -- Suggested Reading -- 5: Synthetic Cannabinoids -- 5.1 Uses -- 5.2 Mechanism -- 5.3 Imaging Findings -- 5.4 Differential Diagnosis -- Suggested Reading -- 6: Crack and Cocaine -- 6.1 Uses -- 6.2 Mechanism -- 6.3 Imaging Findings -- 6.4 Differential Diagnosis -- Suggested Reading -- 7: Amphetamines -- 7.1 Uses -- 7.2 Mechanism -- 7.3 Imaging Findings -- 7.4 Differential Diagnosis -- Suggested Reading -- 8: Opioids -- 8.1 Uses -- 8.2 Mechanism -- 8.3 Imaging Findings -- 8.4 Differential Diagnosis -- Suggested Reading -- 9: Betel Nuts -- 9.1 Uses -- 9.2 Mechanism -- 9.3 Imaging Findings -- 9.4 Differential Diagnosis -- Suggested Reading -- 10: Licorice -- 10.1 Uses -- 10.2 Mechanism -- 10.3 Imaging Findings -- 10.4 Differential Diagnosis -- Suggested Reading -- 11: Centella asiatica -- 11.1 Uses -- 11.2 Mechanism -- 11.3 Imaging Findings -- 11.4 Differential Diagnosis -- Suggested Reading -- Part II: Contrast Agents -- 12: Iodinated Contrast Agents -- 12.1 Uses -- 12.2 Mechanism -- 12.3 Imaging Findings -- 12.4 Differential Diagnosis -- Suggested Reading -- 13: Gadolinium-Based Contrast Agents -- 13.1 Uses. ; 13.2 Mechanism -- 13.3 Imaging Findings -- 13.4 Differential Diagnosis -- Suggested Reading -- 14: Ferumoxytol -- 14.1 Uses -- 14.2 Mechanism of Action -- 14.3 Imaging Findings -- 14.4 Differential Diagnosis -- Suggested Reading -- 15: Pantopaque (Myodil, Iodophenylundecylic Acid) -- 15.1 Uses -- 15.2 Mechanism -- 15.3 Imaging Findings -- 15.4 Differential Diagnosis -- Suggested Reading -- 16: Thorium Dioxide (Thorotrast) -- 16.1 Uses -- 16.2 Mechanism -- 16.3 Imaging Findings -- 16.4 Differential Diagnosis -- Suggested Reading -- Part III: Chemotherapy -- 17: Temozolamide (Temodar) -- 17.1 Uses -- 17.2 Mechanism -- 17.3 Imaging Findings -- 17.4 Differential Diagnosis -- Suggested Reading -- 18: 1,3-Bis(2-Chloroethyl)-1-Nitrosourea (BCNU -- Carmustine) Polymer Wafer (Gliadel) -- 18.1 Uses -- 18.2 Mechanism -- 18.3 Imaging Findings -- 18.4 Differential Diagnosis -- Suggested Reading -- 19: Methotrexate -- 19.1 Uses -- 19.2 Mechanism -- 19.3 Imaging Findings -- 19.4 Differential Diagnosis -- Suggested Reading -- 20: 5-Fluorouracil -- 20.1 Uses -- 20.2 Mechanism -- 20.3 Imaging Findings -- 20.4 Differential Diagnosis -- Suggested Reading -- 21: l-Asparaginase (Elspar/Erwinase) -- 21.1 Uses -- 21.2 Mechanism -- 21.3 Imaging Findings -- 21.4 Differential Diagnosis -- Suggested Reading -- 22: Calcineurin Inhibitors -- 22.1 Uses -- 22.2 Mechanism -- 22.3 Imaging Findings -- 22.4 Differential Diagnosis -- Suggested Reading -- 23: Bromocriptine (Parlodel) and Cabergoline (Dostinex) -- 23.1 Uses -- 23.2 Mechanism -- 23.3 Imaging Findings -- 23.4 Differential Diagnosis -- Suggested Reading -- 24: HiDAC (High-Dose Ara-C -- Cytarabine -- Cytosine Arabinoside -- Cytosar-U -- Depocyt) -- 24.1 Uses -- 24.2 Mechanism -- 24.3 Imaging Findings -- 24.4 Differential Diagnosis -- Suggested Reading. ; Part IV: Anti-Cancer Immunotherapy -- 25: Ipilimumab (MDX-010, Yervoy) -- 25.1 Uses -- 25.2 Mechanism -- 25.3 Imaging Findings -- 25.4 Differential Diagnosis -- Suggested Reading -- 26: Bevacizumab (Avastin) -- 26.1 Uses -- 26.2 Mechanism -- 26.3 Imaging Findings -- 26.4 Differential Diagnosis -- Suggested Reading -- 27: Chimeric Antigen Receptor T-Cell Therapy (Tisagenlecleucel and Axicabtagene Ciloleucel) -- 27.1 Uses -- 27.2 Mechanism -- 27.3 Imaging Findings -- 27.4 Differential Diagnosis -- Suggested Reading -- Part V: Antibiotics, Antiviral Agents, and Vaccines -- 28: Metronidazole (Flagyl) -- 28.1 Uses -- 28.2 Mechanism -- 28.3 Imaging Findings -- 28.4 Differential Diagnosis -- Suggested Reading -- 29: Iodoform -- 29.1 Uses -- 29.2 Mechanism -- 29.3 Imaging Findings -- 29.4 Differential Diagnosis -- Suggested Reading -- 30: Isoniazid -- 30.1 Uses -- 30.2 Mechanism -- 30.3 Imaging Findings -- 30.4 Differential Diagnosis -- Suggested Reading -- 31: Highly Active Antiretroviral Therapy (HAART) -- 31.1 Uses -- 31.2 Mechanism -- 31.3 Imaging Findings -- 31.4 Differential Diagnosis -- Suggested Reading -- 32: Vaccines -- 32.1 Uses -- 32.2 Mechanism -- 32.3 Discussion -- 32.4 Differential Diagnosis -- Suggested Reading -- Part VI: Antiepilectic, Antipsychotic, and General Anesthetic Agents -- 33: Dilantin (Phenytoin Sodium) -- 33.1 Uses -- 33.2 Mechanism -- 33.3 Imaging Findings -- 33.4 Differential Diagnosis -- Suggested Reading -- 34: Valproic Acid (Sodium Valproate, Depakote) -- 34.1 Uses -- 34.2 Mechanism -- 34.3 Imaging Findings -- 34.4 Differential Diagnosis -- Suggested Reading -- 35: Vigabatrin (Sabril) -- 35.1 Uses -- 35.2 Mechanism -- 35.3 Imaging Findings -- 35.4 Differential Diagnosis -- Suggested Reading -- 36: Lithium -- 36.1 Uses -- 36.2 Mechanism -- 36.3 Imaging Findings. ; 36.4 Differential Diagnosis -- Suggested Reading -- 37: Neuroleptics -- 37.1 Uses -- 37.2 Mechanism -- 37.3 Imaging Findings -- 37.4 Differential Diagnosis -- Suggested Reading -- Part VII: Anesthetic and Sedative Agents -- 38: Barbiturates (Pentobarbital) -- 38.1 Uses -- 38.2 Mechanism -- 38.3 Imaging Findings -- Suggested Reading -- 39: Nitrous Oxide (N2O) -- 39.1 Uses -- 39.2 Mechanism -- 39.3 Imaging Findings -- 39.4 Differential Diagnosis -- Suggested Reading -- 40: Propofol -- 40.1 Uses -- 40.2 Mechanism -- 40.3 Imaging Findings -- 40.4 Differential Diagnosis -- Suggested Reading -- Part VIII: Hemostatic and Vasoactive Agents -- 41: Embolic Agents -- 41.1 Uses -- 41.2 Mechanism -- 41.3 Imaging Findings -- 41.4 Differential Diagnosis -- Suggested Reading -- 42: Aspirin and Plavix/Clopidogrel -- 42.1 Uses -- 42.2 Mechanism -- 42.3 Imaging Findings -- 42.4 Differential Diagnosis -- Suggested Reading -- 43: Warfarin (Coumadin) -- 43.1 Uses -- 43.2 Mechanism -- 43.3 Imaging Findings -- 43.4 Differential Diagnosis -- Suggested Reading -- 44: Heparin -- 44.1 Uses -- 44.2 Mechanism -- 44.3 Imaging Findings -- 44.4 Differential Diagnosis -- Suggested Reading -- 45: Tissue Plasminogen Activator (tPA) -- 45.1 Uses -- 45.2 Mechanism -- 45.3 Imaging Findings -- 45.4 Differential Diagnosis -- Suggested Reading -- 46: Oxidized Cellulose -- 46.1 Uses -- 46.2 Mechanism -- 46.3 Imaging Findings -- 46.4 Differential Diagnosis -- Suggested Reading -- 47: Nasal Decongestants -- 47.1 Uses -- 47.2 Mechanism -- 47.3 Imaging Findings -- 47.4 Differential Diagnosis -- Suggested Reading -- Part IX: Cardiovascular Support Agents -- 48: Supplemental Oxygen -- 48.1 Uses -- 48.2 Mechanism -- 48.3 Imaging Findings -- 48.4 Differential Diagnosis -- Suggested Reading -- 49: Hypertonic Saline -- 49.1 Uses -- 49.2 Mechanism. ; 49.3 Imaging Findings -- 49.4 Differential Diagnosis -- Suggested Reading -- 50: Mannitol (1,2,3,4,5, 6-Hexanehexol) -- 50.1 Uses -- 50.2 Mechanism -- 50.3 Imaging Findings -- 50.4 Differential Diagnosis -- Suggested Reading -- 51: Triple H Therapy -- 51.1 Uses -- 51.2 Mechanism -- 51.3 Imaging Findings -- 51.4 Differential Diagnosis -- Suggested Reading -- 52: Angiotensin-Converting Enzyme (ACE) Inhibitors -- 52.1 Uses -- 52.2 Mechanism -- 52.3 Imaging Findings -- 52.4 Differential Diagnosis -- Suggested Reading -- 53: Acetazolamide (Diamox) -- 53.1 Uses -- 53.2 Mechanism -- 53.3 Imaging Findings -- 53.4 Differential Diagnosis -- Suggested Reading -- 54: Amiodarone -- 54.1 Uses -- 54.2 Mechanism -- 54.3 Imaging Findings -- 54.4 Differential Diagnosis -- Suggested Reading -- Part X: Anti-Inflammatory Agents -- 55: Acetominophen (Tylenol, Paracetamol) -- 55.1 Uses -- 55.2 Mechanism -- 55.3 Imaging Findings -- 55.4 Differential Diagnosis -- Suggested Reading -- 56: Natalizumab (Tysabri, Biogen Idec and Elan Pharmaceuticals) -- 56.1 Uses -- 56.2 Mechanism -- 56.3 Imaging Findings -- 56.4 Differential Diagnosis -- Suggested Reading -- 57: Synthetic Corticosteroids -- 57.1 Uses -- 57.2 Mechanism -- 57.3 Imaging Findings -- 57.4 Differential Diagnosis -- Suggested Reading -- Part XI: Dietary Supplements, Homeostatic Agents, and Hormone-Like Drugs -- 58: Manganese in Total Parenteral Nutrition -- 58.1 Uses -- 58.2 Mechanism -- 58.3 Imaging Findings -- 58.4 Differential Diagnosis -- Suggested Reading -- 59: Zinc Oxide (ZnO) -- 59.1 Uses -- 59.2 Mechanism -- 59.3 Imaging Findings -- 59.4 Differential Diagnosis -- Suggested Reading -- 60: Insulin -- 60.1 Uses -- 60.2 Mechanism -- 60.3 Imaging Findings -- 60.4 Differential diagnosis -- Suggested Reading -- 61: Bisphosphonates -- 61.1 Uses -- 61.2 Mechanism. ; 61.3 Imaging Findings.
• Titolo autorizzato: Neuroimaging Pharmacopoeia
• ISBN: 3-031-08774-7
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910633917403321
• Lo trovi qui: Univ. Federico II